Enanta Pharmaceuticals, Inc — Chart, Price & News (NASDAQ:ENTA) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Market Capitalization 411.1 M
Employee 120
Founded 1995
CEO N/A
Website www.enanta.com
Headquarter Massachusetts, United States
FIGI BBG001V9NSB4
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

411.1 M Market capitalization

Price to earnings ratio

-3.12

Price to sales ratio

0

Dividends per share

—

Dividend yield %

—

Notizie

What Makes Enanta Pharmaceuticals (ENTA) a New Buy Stock

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates

Gli EPS di Enanta hanno battuto le aspettative per 0,39$, il fatturato supera le previsioni

Enanta earnings beat by $0.39, revenue topped estimates

Enanta Pharmaceuticals, Inc. (ENTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Baird conferma il rating Outperform sulle azioni di Enanta Pharmaceuticals

Baird reiterates Outperform rating on Enanta Pharmaceuticals stock

Enanta avanza nella pipeline RSV e immunologia con traguardi chiave in vista

Enanta advances RSV and immunology pipeline with key milestones ahead

Agios Pharmaceuticals (AGIO) Surges 18.6%: Is This an Indication of Further Gains?

Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains?

Enanta Pharma CSO Or Yat Sun sells $34k in stock